Section 280E of the Internal Revenue Code is no longer the blunt instrument it was for state-licensed medical marijuana operators. On April 22, 2026, the federal rescheduling of qualifying medical marijuana from Schedule I to Schedule III effectively severed the statutory trigger that had made every licensed cannabis business a "trafficker" in the IRS's view - and blocked the ordinary deductions available to every other legitimate enterprise in America. For operators who spent years paying federal tax on income they never actually kept, the question now is how much of that money can still be recovered, and whether they will move fast enough to preserve the claim.
The mechanics of the old regime were straightforward, and the damage was real. Under Section 280E, cannabis businesses could deduct only their cost of goods sold - the direct cost of products - while expenses like rent, payroll, utilities, and marketing were simply off the table. The result was taxation on a grossly inflated income figure, with effective federal rates routinely reaching 70 to 80 percent of actual net income. A dispensary running tight margins on compliant inventory, investing in dispensary pos software maryland and staff training, and absorbing the fixed costs of a regulated retail environment still owed federal tax as though those costs didn't exist. The burden fell especially hard on vertically integrated operations, where payroll and overhead are substantial, and on single-location dispensaries with no financial buffer.
The legal shift is precise in its scope. The Department of Justice and the Drug Enforcement Administration issued a final order transferring FDA-approved marijuana products and marijuana subject to a qualifying state medical marijuana license from Schedule I to Schedule III, published at 91 Fed. Reg. 22714 (Apr. 28, 2026). Because Section 280E's disallowance applies only to trafficking in Schedule I and II controlled substances, the rescheduling removes the provision's reach for qualifying medical operators. The IRS and Treasury confirmed this directly on April 23, 2026, stating that rescheduling "generally removes section 280E as a bar to claiming deductions and credits" for businesses that no longer traffic in Schedule I or II substances. Adult-use recreational marijuana remains in Schedule I - fully subject to 280E - and the relief is expressly limited to marijuana tied to an FDA-approved product or a qualifying state medical license. That line matters enormously for operators running mixed medical and adult-use operations under one license or one roof.
The Refund Opportunity Is Real - and It Has an Expiration Date
Going forward, the relief is significant: calendar-year medical operators can deduct ordinary and necessary business expenses for all of 2026, not just the portion of the year after April 22. Treasury has indicated a full-year transition rule applies. But the more urgent issue looks backward, and here is where operators need to move deliberately.
The same Treasury release that confirmed the going-forward relief also encouraged the Secretary of the Treasury to consider retrospective relief for prior taxable years in which a state licensee operated under a qualifying state medical marijuana license. That language is meaningful. It signals the government's awareness that 280E produced genuine overpayments for operators who were, by every state-law measure, licensed and compliant businesses - not street-level traffickers. Formal guidance on prior-year relief has not yet been issued. That gap creates both an opportunity and a trap.
The trap is the statute of limitations. Under 26 U.S.C. § 6511(a), a refund claim must be filed within three years from the date the return was filed or two years from the date the tax was paid, whichever is later. For most calendar-year operators, tax year 2022 is either already closed or closing on a rolling basis depending on when returns were filed. Tax year 2023 follows. The limitations clock does not pause while Treasury drafts guidance. An operator who waits for a published IRS form or a formal revenue procedure before acting may find that its highest-overpayment years have lapsed entirely.
The answer, in practice, is a protective refund claim. Filing on Form 1120X for corporations or Form 1040X for individuals preserves every open year under Section 6511 without forcing the IRS to adjudicate the claim before guidance exists. A protective claim does not demand immediate action from the IRS. It keeps the recovery option alive for the day the rules are finalized. The cost of filing is modest. The cost of missing the window is not.
Who Is Most Exposed - and What Needs to Be in Order
Not every cannabis operator is in the same position, and the differences matter for strategy.
- Pure medical operators with clean year-by-year state license records are in the strongest position to recover. Their entire 280E burden is potentially at issue for every open year.
- Mixed medical and adult-use operators face an allocation problem. Medical revenue and expenses now sit outside 280E; adult-use revenue and expenses remain inside it. Treasury has said forthcoming guidance will address exactly this apportionment question. Until it does, any amended return for a mixed operation carries real audit exposure if the allocation methodology isn't defensible.
- Operators with incomplete records are in the most precarious position. Relief will require demonstrating that the business operated under a qualifying state medical license in each year claimed. Transaction-level records, license documentation, and year-by-year filing histories are not optional - they are the evidentiary foundation of any refund claim.
The operators who are moving carefully right now are doing a few things in sequence. They are pulling state license documentation for every open tax year. They are segmenting medical from non-medical revenue and expenses at the transaction level. They are working with qualified tax counsel to assess whether a protective claim is appropriate before Treasury guidance arrives - not filing aggressive amended returns that assume full retroactive relief, but preserving their rights while the rules are written. There is a real difference between those two approaches, and the IRS is likely to notice which is which.
The Broader Implication for Cannabis Retail Finance
For years, 280E distorted the financial reality of cannabis retail in ways that affected everything from capital allocation to lease negotiation. An operator unable to deduct rent had every incentive to hold occupancy costs as low as possible and resist multi-year commitments. Inability to deduct payroll made labor-intensive service models harder to justify on paper. The inability to deduct marketing spend suppressed investment in brand building and customer retention infrastructure. Those distortions did not disappear overnight - businesses made structural decisions under 280E that will take time to unwind - but the underlying economics of licensed cannabis retail have shifted materially for qualifying medical operators.
What hasn't changed is the complexity. Operators still carry state excise taxes, local licensing fees, banking constraints, and the compliance overhead of a heavily regulated retail environment. The end of 280E for medical cannabis is not a simplification of the tax picture - it is a partial correction, one that now requires careful segmentation between medical and adult-use activity, and careful attention to a refund window that is already closing on the most valuable years. The operators who treat this as a routine filing matter will likely leave money behind. The ones who move with precision and appropriate counsel may recover a meaningful share of what they overpaid.
The window is open. It will not stay that way.
